| For Practicing Oncologists |
  See all
 | Articles: Myeloproliferative Dz |
Improved survival in multiple myeloma and the impact of novel therapies
Blood, 03/03/08
Recent major improvement in long-term survival of younger patients with multiple myeloma
Blood, 02/29/08
Pure antiestrogen-induced G1-arrest in myeloma cells results from the reduced kinase activity of cyclin D3/CDK6 complexes whereas apoptosis is mediated by endoplasmic reticulum-dependent caspases
International Journal of Cancer, 02/29/08
 | | Sponsor |
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
Bone Marrow Transplantation, 02/29/08
The potential of histone deacetylase inhibitors for the treatment of multiple myeloma
Leukemia and Lymphoma, 02/28/08
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Blood, 02/28/08
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
Leukemia and Lymphoma, 02/28/08
Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders
Blood, 02/28/08
8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality
Cancer Genetics and Cytogenetics, 02/28/08
Iron overload in myelodysplastic syndromes
Leukemia and Lymphoma, 02/27/08
|
|
Receive daily email updates on Myeloproliferative Dz
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
147 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
|
| Sponsor |
|
